Risk prediction has been used in the primary prevention of cardiovascular disease for >3 decades. Contemporary cardiovascular risk assessment relies on multivariable models, which integrate ...
Students seeking admission to selective schools face the dilemma of trying to get noticed for identical distinctions ...
Hosted on MSN
GRI Bio reports positive study results for chronic lung disease, but stock slumps 20% — what happened?
・The latest findings include RNA-sequencing data showing that GRI-0621 significantly modulated genes associated with lung injury. ・Prior Phase 2a results had already shown favorable safety and ...
The Global Alzheimer’s Platform Foundation ® (GAP) is pleased to welcome Spear Bio, a biotechnology company pioneering wash-free ultrasensitive immunoassay technology, to the Bio-Hermes-002 study.
MOUNT ETNA, Italy (AP) — Guides who take tourists to enjoy the striking views of Sicily’s Mount Etna are up in arms over tougher restrictions imposed by local authorities after a round of eruptions at ...
Hosted on MSN
Nuvation Bio Reports Positive Phase 2 Study Results
Nuvation Bio ( (NUVB)) has provided an update. On November 8, 2025, Nuvation Bio announced positive results from a Phase 2 study of safusidenib in Japanese patients with IDH1-mutant gliomas, showing a ...
Phase 2 of AP-101 in sporadic ALS and mutant SOD1-ALS met its primary safety and tolerability endpoint Clinically meaningful changes in outcome measures and stabilization of biomarkers were observed ...
OpenAI has announced a new study mode for ChatGPT that helps students work through problems step by step — instead of just providing an answer. "When students engage with study mode, they're met with ...
There are various use cases for AI, but one of the most trivial ones is education. Google decided to take matters into its own hands and released the Google Gemini for Education Tool for AI in schools ...
Thermo Fisher Scientific says addressing the need for prefilled syringes is among potential production bottlenecks, the company is working to address. Thermo Fisher’s Accelerator™ Drug Development ...
GRI Bio, Inc. has received a recommendation from the Independent Data Monitoring Committee to continue its Phase 2a study of GRI-0621 for the treatment of idiopathic pulmonary fibrosis (IPF) following ...
With President Donald Trump’s return to the White House and the US government’s digital surveillance machine more powerful than ever, digital privacy should be top of mind. But the digital security ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results